Odyssey raises more than $300M as biotech goes public

May 7, 2026 09:44 PM EDT FinancingStartupsIPOs Odyssey rais­es more than $300M as biotech goes pub­lic in IPO Kyle LaHucik Biotech Correspondent Odyssey Ther­a­peu­tics pulled to­geth­er $279 mil­lion from its ini­tial pub­lic of­fer­ing, the au­toim­mune dis­ease drug de­vel­op­er said Thurs­day night. With its IPO now priced, Odyssey … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER